Assessing COVID-19 Mortality in Serbia’s Capital: Model-Based Analysis of Excess Deaths
The finalized mortality dataset for Belgrade can be safely used in COVID-19 impact analysis. Belgrade experienced a significant increase in mortality during 2020 and 2021, with most of the excess mortality attributable to SARS-CoV-2. Concerns about increased mortality from causes other than COVID-19 in Belgrade seem misplaced as their impact appears negligible.
Authors
- Bojana Matejić (ORCID: https://orcid.org/0000-0001-6372-3298)
- T. Mostic (ORCID: https://orcid.org/0009-0001-7846-8266)
- Dane Cvijanović (ORCID: https://orcid.org/0000-0002-2431-9388)
- Nina Rajović (ORCID: https://orcid.org/0000-0002-8509-0329)
- Nikola Grubor (ORCID: https://orcid.org/0009-0007-7876-1554)
- Nataša Milić (ORCID: https://orcid.org/0000-0001-7074-1187)
- Marija Laban
- Svetlana Miltenovic (ORCID: https://orcid.org/0000-0002-1439-8481)
- Radica Tasic
- Mira Vucevic
Institutions
- Mayo Clinic (US)
- WinnMed (US)
- University of Belgrade (RS)
- Kliničko Bolnički Centar Zvezdara (RS)
- Centar za Promociju Nauke (RS)
- Institute of Public Health of Serbia (RS)
Publication Details
- Journal
- JMIR Public Health and Surveillance
- Published
- 2025-04-17
- DOI
- https://doi.org/10.2196/56877
- Primary Topic
- COVID-19 and healthcare impacts
- Type
- article
- Field-Weighted Citation Impact
- 0.00